Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus

X. Xuan, A. Kojima, T. Murata, T. Mikami, H. Otsuka

研究成果: Article

10 引用 (Scopus)

抄録

The genes encoding the canine herpesvirus (CHV) glycoprotein B (gB), gC and gD homologues have been reported already. However, products of these genes have not been identified yet. Previously, we have identified three CHV glycoproteins, gp145/112, gp80 and gp47 using a panel of monoclonal antibodies (MAbs). To determine which CHV glycoprotein corresponds to gB, gC or gD, the putative genes of gB, gC, and gD of CHV were inserted into the thymidine kinase gene of vaccinia virus LC16mO strain under the control of the early-late promoter for the vaccinia virus 7.5-kilodalton polypeptide. We demonstrated here that gp145/112, gp80 and gp47 were the translation products of the CHV gB, gC and gD genes, respectively. The antigenic authenticity of recombinant gB, gC and gD were confirmed by a panel of MAbs specific for each glycoprotein produced in CHV-infected cells. Immunization of mice with these recombinants produced high titers of neutralizing antibodies against CHV. These results suggest that recombinant vaccinia viruses expressing CHV gB, gC and gD may be useful to develop a vaccine to control CHV infection.

元の言語English
ページ(範囲)1003-1010
ページ数8
ジャーナルArchives of Virology
142
発行部数5
DOI
出版物ステータスPublished - 06-06-1997

Fingerprint

Vaccinia virus
Herpesviridae
Canidae
Glycoproteins
Genes
Monoclonal Antibodies
Herpesviridae Infections
Thymidine Kinase
Neutralizing Antibodies
Canid herpesvirus 1 glycoprotein B
Immunization
Vaccines
Peptides

All Science Journal Classification (ASJC) codes

  • Virology

これを引用

Xuan, X. ; Kojima, A. ; Murata, T. ; Mikami, T. ; Otsuka, H. / Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus. :: Archives of Virology. 1997 ; 巻 142, 番号 5. pp. 1003-1010.
@article{fa9fb808646d4b42b785e2097ef3bb5a,
title = "Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus",
abstract = "The genes encoding the canine herpesvirus (CHV) glycoprotein B (gB), gC and gD homologues have been reported already. However, products of these genes have not been identified yet. Previously, we have identified three CHV glycoproteins, gp145/112, gp80 and gp47 using a panel of monoclonal antibodies (MAbs). To determine which CHV glycoprotein corresponds to gB, gC or gD, the putative genes of gB, gC, and gD of CHV were inserted into the thymidine kinase gene of vaccinia virus LC16mO strain under the control of the early-late promoter for the vaccinia virus 7.5-kilodalton polypeptide. We demonstrated here that gp145/112, gp80 and gp47 were the translation products of the CHV gB, gC and gD genes, respectively. The antigenic authenticity of recombinant gB, gC and gD were confirmed by a panel of MAbs specific for each glycoprotein produced in CHV-infected cells. Immunization of mice with these recombinants produced high titers of neutralizing antibodies against CHV. These results suggest that recombinant vaccinia viruses expressing CHV gB, gC and gD may be useful to develop a vaccine to control CHV infection.",
author = "X. Xuan and A. Kojima and T. Murata and T. Mikami and H. Otsuka",
year = "1997",
month = "6",
day = "6",
doi = "10.1007/s007050050135",
language = "English",
volume = "142",
pages = "1003--1010",
journal = "Archives of Virology",
issn = "0304-8608",
publisher = "Springer Wien",
number = "5",

}

Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus. / Xuan, X.; Kojima, A.; Murata, T.; Mikami, T.; Otsuka, H.

:: Archives of Virology, 巻 142, 番号 5, 06.06.1997, p. 1003-1010.

研究成果: Article

TY - JOUR

T1 - Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus

AU - Xuan, X.

AU - Kojima, A.

AU - Murata, T.

AU - Mikami, T.

AU - Otsuka, H.

PY - 1997/6/6

Y1 - 1997/6/6

N2 - The genes encoding the canine herpesvirus (CHV) glycoprotein B (gB), gC and gD homologues have been reported already. However, products of these genes have not been identified yet. Previously, we have identified three CHV glycoproteins, gp145/112, gp80 and gp47 using a panel of monoclonal antibodies (MAbs). To determine which CHV glycoprotein corresponds to gB, gC or gD, the putative genes of gB, gC, and gD of CHV were inserted into the thymidine kinase gene of vaccinia virus LC16mO strain under the control of the early-late promoter for the vaccinia virus 7.5-kilodalton polypeptide. We demonstrated here that gp145/112, gp80 and gp47 were the translation products of the CHV gB, gC and gD genes, respectively. The antigenic authenticity of recombinant gB, gC and gD were confirmed by a panel of MAbs specific for each glycoprotein produced in CHV-infected cells. Immunization of mice with these recombinants produced high titers of neutralizing antibodies against CHV. These results suggest that recombinant vaccinia viruses expressing CHV gB, gC and gD may be useful to develop a vaccine to control CHV infection.

AB - The genes encoding the canine herpesvirus (CHV) glycoprotein B (gB), gC and gD homologues have been reported already. However, products of these genes have not been identified yet. Previously, we have identified three CHV glycoproteins, gp145/112, gp80 and gp47 using a panel of monoclonal antibodies (MAbs). To determine which CHV glycoprotein corresponds to gB, gC or gD, the putative genes of gB, gC, and gD of CHV were inserted into the thymidine kinase gene of vaccinia virus LC16mO strain under the control of the early-late promoter for the vaccinia virus 7.5-kilodalton polypeptide. We demonstrated here that gp145/112, gp80 and gp47 were the translation products of the CHV gB, gC and gD genes, respectively. The antigenic authenticity of recombinant gB, gC and gD were confirmed by a panel of MAbs specific for each glycoprotein produced in CHV-infected cells. Immunization of mice with these recombinants produced high titers of neutralizing antibodies against CHV. These results suggest that recombinant vaccinia viruses expressing CHV gB, gC and gD may be useful to develop a vaccine to control CHV infection.

UR - http://www.scopus.com/inward/record.url?scp=0031027848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031027848&partnerID=8YFLogxK

U2 - 10.1007/s007050050135

DO - 10.1007/s007050050135

M3 - Article

C2 - 9191864

AN - SCOPUS:0031027848

VL - 142

SP - 1003

EP - 1010

JO - Archives of Virology

JF - Archives of Virology

SN - 0304-8608

IS - 5

ER -